Reducing Opioid Prescription After Kidney Stone Removal Surgery

Reducing Opioids After Percutaneous Stone Surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05353478

Enrollment

Registered

2022-04-29

Start date

2022-06-06

Completion date

2027-08-01

Last updated

2026-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Stone

Keywords

Percutaneous Nephrolithotomy (PCNL)

Brief summary

The purpose of this study is to implement and assess a standard way of prescribing opioid pain medication following PCNL (a kidney stone removal surgery) to ensure patients are being discharged with an appropriate quantity of pain management medication.

Detailed description

Participants in this study will have their opioid pain medication prescription at discharge following PCNL (Percutaneous Nephrolithotomy, a kidney stone removal surgery) determined by an algorithm in addition to physician judgement. The goal of the algorithm is help physicians refine pain medication prescribing patterns for patients who have undergone PCNL in order to discharge patients with an appropriate quantity of pain management medication. The effectiveness of the algorithm will be assessed through participant surveys. Participants will complete a brief online survey on Days 3, 7, and 14 following hospital discharge and another phone-based survey 26-30 days after hospital discharge.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

\- Patients undergoing percutaneous nephrolithotomy at Mayo Clinic Rochester.

Exclusion criteria

* Unable or unwilling to provide informed consent. * Patients who require Intensive Care Unit admission after surgery. * Patients who have Clavien grade III or greater postoperative complications requiring additional intervention \< 30 days after index procedure.

Design outcomes

Primary

Measure	Time frame	Description
Unused opioid prescriptions	30 days	Number of unused opioids following recovery from percutaneous nephrolithotomy

Secondary

Measure	Time frame	Description
Unfilled opioid prescriptions	30 days	Number of unfilled opioid prescriptions following recovery from percutaneous nephrolithotomy
Opioid prescription refills	30 days	Number of opioid prescription refills following recovery from percutaneous nephrolithotomy

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKevin Koo, MD

Mayo Clinic

Outcome results